Home
  >  
Section 50
  >  
Chapter 49,365

Innovation meets quality: moving cellular therapies at the National Institutes for Health from bench to bedside

Read, E.J.

CytoTherapy 6(6): 626-628

2004


ISSN/ISBN: 1465-3249
PMID: 15764029
DOI: 10.1080/14653240410005302
Accession: 049364304

The National Institutes of Health (NIH) Department of Transfusion Medicine has supported clinical investigation in cellular therapies over the past 20 years. This experience, which encompasses product development research, quality system design and product manufacturing for a wide range of early phase clinical trials, provides a firm basis for future work with novel stem cell therapies.

PDF emailed within 0-6 h: $19.90